GANX - Gain Therapeutics GAAP EPS of -$1.37 beats by $0.25 revenue of $0.16M beats by $0.01M March, 24 2022 09:29 AM Gain Therapeutics Inc. Gain Therapeutics press release (NASDAQ:GANX): FY GAAP EPS of -$1.37 beats by $0.25. Revenue of $0.16M (+433.3% Y/Y) beats by $0.01M. For further details see: Gain Therapeutics GAAP EPS of -$1.37 beats by $0.25, revenue of $0.16M beats by $0.01M